European Stroke Organisation guideline on endarterectomy and stenting for carotid artery stenosis. (June 2021)

• Record Type: Journal Article
• Authors: Bonati, Leo H; Kakkos, Stavros; Berkefeld, Joachim; de Borst, Gert J; Bulbulia, Richard; Halliday, Alison; van Herzeele, Isabelle; Koncar, Igor; McCabe, Dominick JH; Lal, Avtar; Ricco, Jean-Baptiste; Ringleb, Peter; Taylor-Rowan, Martin; Eckstein, Hans-Henning
• Is Part Of: European stroke journal. Volume 6:Number 2(2021)
• Page Start: I
• Page End: I
• Publication Date: 2021-06
• Subjects: Carotid stenosis -- endarterectomy -- stenting -- medical therapy -- stroke -- transient ischaemic attack; Cerebrovascular disease -- Periodicals; 616.8005
• DOI: 10.1177/23969873211026990
• Languages: English
• ISSNs: 2396-9873

Abstract

Atherosclerotic stenosis of the internal carotid artery is an important cause of stroke. The aim of this guideline is to analyse the evidence pertaining to medical, surgical and endovascular treatment of patients with carotid stenosis. These guidelines were developed based on the ESO standard operating procedure and followed the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. The working group identified relevant questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote recommendations. Based on moderate quality evidence, we recommend carotid endarterectomy (CEA) in patients with ≥60–99% asymptomatic carotid stenosis considered to be at increased risk of stroke on best medical treatment (BMT) alone. We also recommend CEA for patients with ≥70–99% symptomatic stenosis, and we suggest CEA for patients with 50–69% symptomatic stenosis. Based on high quality evidence, we recommend CEA should be performed early, ideally within two weeks of the last retinal or cerebral ischaemic event in patients with ≥50–99% symptomatic stenosis. Based on low quality evidence, carotid artery stenting (CAS) may be considered in patients < 70 years old with symptomatic ≥50–99% carotid stenosis. Several randomised trials supporting these recommendations were started decades ago, and BMT, CEA and CAS have evolved since. The results of another large trial comparing outcomes after CAS versus CEA in patients with asymptomatic stenosis are anticipated in the near future. Further trials are needed to reassess the benefits of carotid revascularisation in combination with modern BMT in subgroups of patients with carotid stenosis.